After spending time on the FDA's Category 2 list flagged for "significant safety concerns" BPC-157 is now being removed from that restrictive classification and scheduled for a Pharmacy Compounding Advisory Committee (PCAC) review on July 23, 2026
Biochem Biophys Res Commun 209:227233 Mulcahy RT, Untawale S, Gipp JJ (1994) Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells
Environmental modifications: If possible, identify and eliminate the source of mold exposure
Anti-Doping Agency (USADA) Sport Integrity Australia and related communications state it is not approved by the TGA
Purity: 99% Medical-Grade (validated via HPLC)
Physiol Rev 99:665706 Rousselle P, Braye F, Dayan G (2018) Re-epithelialization of adult skin wounds: cellular mechanisms and therapeutic strategies